Apollomics (APLM) director Hong-Jung Chen discloses initial shares, RSUs, options and warrants

Rhea-AI Filing Summary

Apollomics Inc. director Hong-Jung Chen filed an initial ownership report detailing equity and derivative holdings in the company. Chen directly holds 2,120 Class A Ordinary Shares. In addition, Chen has restricted stock units representing 2,000 Class A Ordinary Shares, with 500 units vested on February 9, 2026 and 500 more vesting on each of March 15, June 15 and September 15, 2026, subject to continued service.

Chen also holds stock options over 2,290 Class A Ordinary Shares at an exercise price of $75.00 per share, which are fully vested following a 1-for-100 reverse stock split adjustment. A second option grant covers 2,028 Class A Ordinary Shares at an exercise price of $6.20 per share and will vest in full on March 31, 2026, subject to continued service. The filing further discloses warrants linked to 304 Class A Ordinary Shares, reflecting an adjusted exercise price of $1,150.00 per full share, as each warrant is exercisable for 0.01 Class A Ordinary Share at $11.50 per warrant.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

CHEN HONG-JUNG

(Last) (First) (Middle)

989 E HILLSDALE BLVD, SUITE 220

(Street)

FOSTER CITY CALIFORNIA 94404

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Apollomics Inc. [ APLM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Ordinary Shares	2,120	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	(1)	Class A Ordinary Shares	2,000	(2)	D
Options	03/31/2025(3)	03/31/2034	Class A Ordinary Shares	2,290	$75(3)	D
Options	03/31/2026(4)	03/31/2035	Class A Ordinary Shares	2,028	$6.2	D
Warrants	04/28/2023	03/29/2028	Class A Ordinary Shares	304(5)	$1,150(5)	D

Explanation of Responses:

1. The restricted stock units were vested with respect to 500 shares upon grant on February 9, 2026, with an additional 500 shares vesting on each of March 15, 2026, June 15, 2026 and September 15, 2026.

2. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share.

3. The options are fully vested and exercisable. The number of shares and the exercise price have been adjusted to reflect a 1-for-100 reverse stock split.

4. The options will vest in full on March 31, 2026, subject to the Reporting Person's continued service.

5. Reflects the adjusted exercise price of $1,150.00 per full share, as each warrant is exercisable for 0.01 Class A Ordinary Share at a price of $11.50 per warrant.

Remarks:

This Initial Statement of Beneficial Ownership is being filed in connection with the enactment of the Holding Foreign Insiders Accountable Act and the rules and regulations adopted in association therewith.

	/s/ Chen, Hong-Jung (Moses)	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Apollomics (APLM) Form 3 filing by Hong-Jung Chen show?

The Form 3 shows director Hong-Jung Chen’s initial ownership in Apollomics, including 2,120 Class A Ordinary Shares, multiple stock option grants, restricted stock units, and warrants tied to additional Class A Ordinary Shares.

How many Apollomics (APLM) Class A Ordinary Shares does Hong-Jung Chen directly hold?

Hong-Jung Chen directly holds 2,120 Class A Ordinary Shares of Apollomics. This position is separate from additional exposure through restricted stock units, stock options, and warrants that could increase effective ownership if and when those instruments are settled or exercised.

What restricted stock units does Hong-Jung Chen report in Apollomics (APLM)?

Chen reports restricted stock units tied to 2,000 Class A Ordinary Shares. 500 units vested on February 9, 2026, with 500 more vesting on each of March 15, June 15, and September 15, 2026, provided Chen continues in service.

What stock options are disclosed for Hong-Jung Chen in Apollomics (APLM)?

Chen holds stock options over 2,290 Class A Ordinary Shares at $75.00 per share, fully vested after a 1-for-100 reverse split adjustment, plus options over 2,028 shares at $6.20 per share that will vest in full on March 31, 2026.

How did Apollomics (APLM) reverse stock split affect Chen’s options?

The filing states Chen’s options were adjusted for a 1-for-100 reverse stock split. Both the number of shares covered and the exercise prices were recalculated to reflect this split, while maintaining the overall economic value of the grants.

What warrants linked to Apollomics (APLM) shares does Hong-Jung Chen hold?

Chen holds warrants relating to 304 Class A Ordinary Shares. Each warrant is exercisable for 0.01 share at $11.50 per warrant, which equates to an adjusted exercise price of $1,150.00 per full share based on the filing.